Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: jayhawk969 who wrote (22937)	7/8/1998 12:31:00 PM
From: Phil Cressman	Read Replies (1) \| Respond to of 32384

Any timetable for LGND/SRGN response to FDA and when approval is likely to be received for ONTAK. It seems reasonable that SRGN knew of the FDA's requirements prior to receiving the letter from them and since no new data/testing was required it can't take that long to give the FDA the information they requested, or can it? SRGN at around 50 cents with an upside of 75 cents within a few months seems worth a flutter.